Identification of GTF2IRD1 as a novel transcription factor essential for acute myeloid leukemia
Y. Heshmati, G. Turkoz, J. Zawacka, M. Dimitriou, A. Harisankar, J. Bostrom, H. Cai, N. Kadri, M. Altun, H. Qian, J. Walfridsson
This study identifies GTF2IRD1 as a novel transcription factor essential for AML cell survival and disease progression, with potential therapeutic implications.
bioRxiv · Aug 9, 2022 · PreprintCancer Biology